Avaleht › KOKH › Alabama › Birmingham
KOKH kliinilised uuringud linnas Birmingham, AL
17 uuringut haiguse KOKH jaoks otsivad osalejaid linnas Birmingham ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
VärbamineFaas 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
VärbamineFaas 2
- University of Alabama at Birmingham, Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
VärbamineFaas 4
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
VärbamineFaas 2
- Research Site, Birmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
VärbamineFaas 2
- University of Alabama, Birmingham
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
VärbamineFaas 1
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
VärbamineFaas 2/3
- University of Alabama at Birmingham Lung Health Center, Birmingham
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
VärbamineFaas 3
- GC2501 Study Site 106, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
VärbamineVaatlusuuring
- Cooper Green Mercy Hospital, Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPD
VärbamineFaas 3
- University of Alabama, Lung Health Center, Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Värbamine
- The University of Alabama at Birmingham, Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- University of Alabama at Birmingham, Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Värbamine
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Värbamine
- University of Alabama at Birmingham, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
VärbamineVaatlusuuring
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
VärbamineFaas 4
- University of Alabama at Birmingham, Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Värbamine
- UAB School of Medicine/Lung Health Center, Birmingham
KOKH uuringud teistes linnades
- Philadelphia, PA23 uuringut
- Miami, FL18 uuringut
- Boston, MA17 uuringut
- Houston, TX15 uuringut
- Orlando, FL15 uuringut
- Baltimore, MD14 uuringut
- Chicago, IL14 uuringut
- Dallas, TX12 uuringut
- Pittsburgh, PA12 uuringut
- New York City, NY11 uuringut
- Ann Arbor, MI10 uuringut
- Winston-Salem, NC9 uuringut
Muud uuringud linnas Birmingham
- Vähk (kõik liigid)30 uuringut
- Rinnavähk24 uuringut
- Rasvumine23 uuringut
- Munasarjavähk23 uuringut
- Mitteväikerakuline kopsuvähk22 uuringut
- Äge müeloidne leukeemia21 uuringut
- Müeloom18 uuringut
- Kardiovaskulaarsed haigused17 uuringut
- Ülekaalulisus16 uuringut
- Endomeetriumivähk16 uuringut
- 2. tüüpi diabeet16 uuringut
- Tsüstiline fibroos16 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.